BACKGROUND: Although Nigeria has the highest burden of sickle cell disease (SCD) worldwide, there is still variable and poor utilisation of standard-of-care practices for SCD patients in the country. METHODS: This was a questionnaire survey of doctors in some dedicated SCD clinics in Nigeria in order to document the facilities available and common management practices. RESULTS: There were responses from 18 clinics based in 11 institutions. The number of patients being followed in each centre ranged from 15 to approximately 11 000. All clinics provided malaria prophylaxis and folic acid routinely to their patients. Only eight clinics prescribe penicillin prophylaxis. Eight prescribe hydroxyurea to patients who can afford it when indicated. All of the centres except three have electronic cell counters, but all had access to haemoglobin electrophoresis. Three had high-performance liquid chromatography machines installed but none was being routinely used. One institution had a functioning molecular biology laboratory. There is no official newborn screening programme in the country. All had access to microbiology and chemistry laboratories. Nine institutions had CT, six had MRI and three had transcranial Doppler facilities. CONCLUSION: The care available for SCD in Nigeria is still suboptimal and there is an urgent need for concerted effort to tackle the problem, but to make a significant impact on the burden of the disease would require more focus at the primary care level. Some steps to achieving this are outlined.
BACKGROUND: Although Nigeria has the highest burden of sickle cell disease (SCD) worldwide, there is still variable and poor utilisation of standard-of-care practices for SCDpatients in the country. METHODS: This was a questionnaire survey of doctors in some dedicated SCD clinics in Nigeria in order to document the facilities available and common management practices. RESULTS: There were responses from 18 clinics based in 11 institutions. The number of patients being followed in each centre ranged from 15 to approximately 11 000. All clinics provided malaria prophylaxis and folic acid routinely to their patients. Only eight clinics prescribe penicillin prophylaxis. Eight prescribe hydroxyurea to patients who can afford it when indicated. All of the centres except three have electronic cell counters, but all had access to haemoglobin electrophoresis. Three had high-performance liquid chromatography machines installed but none was being routinely used. One institution had a functioning molecular biology laboratory. There is no official newborn screening programme in the country. All had access to microbiology and chemistry laboratories. Nine institutions had CT, six had MRI and three had transcranial Doppler facilities. CONCLUSION: The care available for SCD in Nigeria is still suboptimal and there is an urgent need for concerted effort to tackle the problem, but to make a significant impact on the burden of the disease would require more focus at the primary care level. Some steps to achieving this are outlined.
Authors: Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams Journal: Blood Date: 2010-06-08 Impact factor: 22.113
Authors: K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill Journal: Blood Date: 1998-01-01 Impact factor: 22.113
Authors: F M Gill; L A Sleeper; S J Weiner; A K Brown; R Bellevue; R Grover; C H Pegelow; E Vichinsky Journal: Blood Date: 1995-07-15 Impact factor: 22.113
Authors: Shehu U Abdullahi; Michael R DeBaun; Lori C Jordan; Mark Rodeghier; Najibah A Galadanci Journal: Pediatr Neurol Date: 2019-01-17 Impact factor: 3.372
Authors: Amanda R Burnham-Marusich; Chinenye O Ezeanolue; Michael C Obiefune; Wei Yang; Alice Osuji; Amaka G Ogidi; Aaron T Hunt; Dina Patel; Echezona E Ezeanolue Journal: Public Health Genomics Date: 2016-09-10 Impact factor: 2.000
Authors: Bamidele O Tayo; Titilola S Akingbola; Santosh L Saraf; Binal N Shah; Chinedu A Ezekekwu; Omowunmi Sonubi; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk Journal: Am J Hematol Date: 2018-05-14 Impact factor: 10.047
Authors: Shehu U Abdullahi; Binta J Wudil; Halima Bello-Manga; Aisha B Musa; Safiya Gambo; Najibah A Galadanci; Hauwa Aminu; Aliyu Tijjani Gaya; Surayya Sanusi; Musa A Tabari; Aisha Galadanci; Awwal Borodo; Muhammed S Abba; Abdu H Dambatta; Lawal Haliru; Awwal Gambo; Holly Cassell; Mark Rodeghier; Djamila L Ghafuri; Brittany V Covert Greene; Kathleen Neville; Adetola A Kassim; Fenella Kirkham; Edwin Trevathan; Lori C Jordan; Muktar H Aliyu; Michael R DeBaun Journal: Pediatr Hematol Oncol Date: 2020-11-25 Impact factor: 1.969
Authors: Titilola S Akingbola; Bamidele O Tayo; Babatunde Salako; Jennifer E Layden; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk; Santosh L Saraf Journal: Hemoglobin Date: 2014-06-18 Impact factor: 0.849